Weilan Stellar completes hundreds of millions of RMB in angel+ funding round, racing to build world's first high-temperature superconducting stellarator
It plans to complete the world's first medium-sized high-temperature stellarator by 2027.
It plans to complete the world's first medium-sized high-temperature stellarator by 2027.
We invite you to revisit the July "highlight reel."
Recently, **NewPro Bioworks (Shanghai Xinyicui Biotechnology Co., Ltd.) announced the completion of a Pre-A funding round worth tens of millions of RMB**. This round was jointly led by **SSCI Leading Fund and Aochuang Pioneer Fund — the latter established by Dalton Venture in partnership with listed industry player OPM Biosciences, making it the first bio-manufacturing industry CVC fund in the Yangtze River Delta region**. Meanwhile, the company's self-developed precision-fermented lactoferrin product
Counselor Vitality
MiniMax H3 is taking the next step: abandoning the old architecture and building a new tokenizer.
On August 3, **Shanghai Initiative Technology Co., Ltd. (hereinafter referred to as "Initiative Technology") announced the completion of a 330 million RMB angel funding round, setting a new record for angel-round financing in China's brain-computer interface sector. This round was led by CASSTAR, with co-investment from Dalton Venture, Legend Star, Unity Ventures, Inno Angel Fund, BGI Songhe Bio Fund, LYFE Capital, and Jiadao Capital**. The proceeds will be mainly used for facility expansion, equipment upgrades, and clinical trial advancement.
From "Can Move" to "Can Get Things Done"
The domestic invasive brain-computer interface company with the most comprehensive product line
"Saving the model through a detour" — a pun on 曲线救国 ("saving the nation through a detour," a historical euphemism for indirect approaches), applied to AI model development or distribution strategies that work around direct obstacles (regulatory, technical, or competitive).
"Big Club's Game"